Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Reponex Pharmaceuticals Aps patents


Recent patent applications related to Reponex Pharmaceuticals Aps. Reponex Pharmaceuticals Aps is listed as an Agent/Assignee. Note: Reponex Pharmaceuticals Aps may have other listings under different names/spellings. We're not affiliated with Reponex Pharmaceuticals Aps, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "R" | Reponex Pharmaceuticals Aps-related inventors


Methods and compositions for enhancing pulmonary host defense in acute and chronic radiation syndrome, therapeutic radiation intervention and cancer therapy

Methods and compositions for treating and alleviating symptoms of irradiation injuries, therapeutic radiation intervention and/or anti-cancer therapies in a subject via pulmonary airway administration of granulocyte macrophage colony stimulating factor (gm-csf) or a compound with similar affinity to the specific alveolar gm-csf receptor to enhance pulmonary host defense are provided.. . ... Reponex Pharmaceuticals Aps

Compositions for the treatment of peritonitis

The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and antimicrobial agents for the treatment, pre-emptive treatment or prevention of infectious peritonitis or intra-abdominal infection by intraperitoneal administration of the compositions.. . ... Reponex Pharmaceuticals Aps

Compositions comprising granulocyte-macrophage colony-stimulating factor for the treatment of inflammatory bowel disease

The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor and fosfomycin for the treatment, prevention or alleviation of an inflammatory bowel disease such as crohn's disease, ulcerative colitis or necrotizing enterocolitis of newborn and premature infants by administration of the compositions into the intestinal lumen.. . ... Reponex Pharmaceuticals Aps

Compositions for promoting the healing of wounds

The present invention provides compositions comprising granulocyte-macrophage colony-stimulating factor (gm-csf), sucrose octasulfate or sucralfate and hyaluronic acid for the treatment, pre-emptive treatmentor prophylaxis of ulcers, wounds and other injuries to the skin or membranes of the body. Other aspects of the invention are methods of treatment or prevention using the compositions described, as well as an application device for use in the methods provided.. ... Reponex Pharmaceuticals Aps

Compositions for treating lung infections by airway administration

The present invention provides compositions comprising as an essential feature granulocyte-macrophage colony-stimulating factor (gm-csf) together with fosfomycin for the treatment of bacterial lung infections by administration via the airways.. . ... Reponex Pharmaceuticals Aps








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Reponex Pharmaceuticals Aps in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Reponex Pharmaceuticals Aps with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###